Association of LAG-3 expression in circulating T cells and response to combination temozolomide (TMZ) and nivolumab (NIVO) in advanced neuroendocrine neoplasms (NENs): Results from an investigator-initiated phase 2 trial.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Vineeth Sukrithan, Brooke Benner, Lai Wei, Ashima Goyal, Ye Zhou, Sheryl-Ann Suffren, Carly Pilcher, Gwen Christenson, Nancy Curtis, Emily Schwarz, Himanshu Savardekar, Ruthann Norman, Barbara Kleiber, Robert Wesolowski, Gregory Alan Otterson, Claire F. Verschraegen, William Edgar Carson, Manisha H. Shah, Bhavana Konda, Dwight Hall Owen
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4281656766